Product Information
OXCARBAZEPINE 300 MG TABLET is a generic product labeled by AvPAK, priced at $0.1637 per EA under NDC 50268068015. Its NADAC has been published 150 times since Oct 11, 2023.
FDA first approved this application on Jan 11, 2022. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
300 mg/1
Manufacturer
AvPAKNDC
50268068015
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
OXCARBAZEPINEApproval Type
Generic (ANDA)
FDA Application
ANDA215939FDA Approved
1/11/2022
TE Code
AB
On Market Since
6/7/2023
Pharmacological Classes
Price Statistics
The NADAC for OXCARBAZEPINE 300 MG TABLET has been published 150 times since Oct 11, 2023, and over the history we have for it it has declined 15.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1637 per EA |
|---|---|
| All-time high | $0.2109 (Apr 10, 2024) |
| All-time low | $0.1454 (Nov 20, 2024) |
| 52-week high | $0.1747 |
| 52-week low | $0.1635 |
| Median price | $0.1748 |
| Average price | $0.1800 |
| Largest weekly change | +25.1% (Aug 21, 2024) |
| Weeks tracked | 150 |
| Tracking since | Oct 11, 2023 |
Generic Alternatives
The matcher finds 8 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of OXCARBAZEPINE 300 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for OXCARBAZEPINE 300 MG TABLET, manufactured by AvPAK, is $0.1637 per EA (NDC 50268068015), effective Aug 19, 2026.
How has the price of OXCARBAZEPINE 300 MG TABLET changed over time?
Over the history we have for it, the NADAC for OXCARBAZEPINE 300 MG TABLET has declined 15.8%. It has been tracked across 150 weekly CMS publications since Oct 11, 2023.
What are the highest and lowest recorded NADAC prices for OXCARBAZEPINE 300 MG TABLET?
Since Oct 11, 2023, the NADAC for OXCARBAZEPINE 300 MG TABLET has ranged from a low of $0.1454 (Nov 20, 2024) to a high of $0.2109 (Apr 10, 2024), with a median of $0.1748 per EA.
Are there cheaper alternatives to OXCARBAZEPINE 300 MG TABLET?
8 manufacturers publish a NADAC-priced product with the same active ingredient and strength as OXCARBAZEPINE 300 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures OXCARBAZEPINE 300 MG TABLET?
OXCARBAZEPINE 300 MG TABLET (NDC 50268068015) is labeled by AvPAK, and CMS classifies it as a generic product.